Tether has formally moved to gain control of Juventus through a full takeover bid. The move highlights crypto firms expanding from sponsorships into direct footballTether has formally moved to gain control of Juventus through a full takeover bid. The move highlights crypto firms expanding from sponsorships into direct football

Tether Moves to Take Control of Juventus Football Club

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • Tether has formally moved to gain control of Juventus through a full takeover bid.
  • The move highlights crypto firms expanding from sponsorships into direct football club ownership.

Tether’s move to take over Juventus is now entering a more serious phase. The world’s largest stablecoin issuer has submitted an all-cash bid for a majority stake in the Turin club. The bid comes in at roughly €1.1 billion and is focused on the Exor-held block of shares, long anchored by the Agnelli family’s century-old stewardship of Juventus.

Tether Signals Control Ambitions With Majority Juventus Bid

The offer includes the purchase of approximately 65.4% of Juventus shares at a price of €2.66 per share. This figure is above the market price before the official submission and signals a clear intention to take operational control of the club. Previously, Tether had already amassed a minority stake in Juventus, reaching double digits, making it the second-largest shareholder after Exor.

However, the response from the former club has been rather cool. Exor has insisted that Juventus is not for sale and that the Agnelli family’s ownership is not in a position to sell. The message underscored that, for now, the deal sits squarely in a difficult negotiating phase.

Behind this maneuver, Juventus’s financial condition is a crucial factor. The club hasn’t recorded an annual profit for a long time, and its business performance is often pressured by operational costs and fluctuating on-field performance. This situation opens up space for investors with a long-suffering approach and a different approach than traditional owners. Furthermore, the acquisition offer also includes a commitment to invest up to €1 billion to strengthen the club’s foundations after the takeover.

The shift lines up with a wider pattern, as crypto firms push past simple sponsorships and step into owning major real-world assets. Juventus, with its global following and deep legacy, fits neatly into that approach.

On the other hand, on December 10, we reported on the launch of QVAC Health, a platform that unifies fitness and health data through device-based AI. The system combines biometric readings, training logs, nutrition, and medication reminders in a single encrypted interface that remains active even offline.

At the end of November, we also highlighted the purchase of 26 tons of gold during the third quarter of 2025, surpassing the accumulation of global central banks during the same period. The more than 50% increase in gold prices this year has contributed to the tightening of physical supply in the market.

Additionally, on October 25, we reported on a Tether partnership with Rumble to introduce a Bitcoin tipping feature for creators. The feature is scheduled to launch this December.

]]>
Market Opportunity
Overtake Logo
Overtake Price(TAKE)
$0.02156
$0.02156$0.02156
+4.00%
USD
Overtake (TAKE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09